Navigation Links
NPS Pharmaceuticals Reports 2007 Financial Results
Date:3/13/2008

ceuticals is developing specialty therapeutics for gastrointestinal and endocrine disorders with high unmet medical need. The company is currently advancing two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs with strategic partnerships with Amgen, GlaxoSmithKline, Kirin, and Nycomed. Additional information is available at http://www.npsp.com.

Statements made in this press release, which are not historical in nature, constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These statements are based on the company's current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Risks associated to NPS's business include, but are not limited to, the risk of successfully executing its preclinical and clinical studies and gaining marketing approvals for GATTEX and NPSP558, the risks associated with the company's auction-rate securities, the risk that the steps NPS has taken or is taking to address the material weakness will be adequate or that future material weaknesses or control deficiencies will be identified, as well as other factors expressed in NPS's periodic filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K and Form 10-Qs. All information in this press release is as of the date of this release and NPS undertakes no duty to update this information.


'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
2. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
3. Keryx Biopharmaceuticals to Present at the Cowen and Company 28th Annual Health Care Conference
4. Nventa Biopharmaceuticals Reports Full Year 2007 and Fourth Quarter Financial Results
5. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
6. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs
8. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
9. Onyx Pharmaceuticals to Present at Cowen and Company Health Care Conference
10. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
11. VIA Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Boston, MA (PRWEB) July 30, 2014 ... communication (UC) and collaboration company, is proud to ... and account management positions in their Boston, Charleston ... in response to the increased demand for hosted ... enhance operational efficiency and reduce cost. , SoundConnect ...
(Date:7/29/2014)... 29, 2014   Sequenom, Inc. (NASDAQ: ... innovative genetic analysis solutions, and Mayo Medical Laboratories ... in the United States , have ... and applications. "We have great appreciation for ... and we welcome the opportunity to partner with the ...
(Date:7/29/2014)... team of researchers has created a new way ... textures. These surfaces, made by self-assembly of carbon ... including controllable mechanical stiffness and strength, or ... direction. , "We have demonstrated that mechanical forces ... complex three-dimensional microstructures, and that we can independently ...
(Date:7/29/2014)... , July 29, 2014 According ... (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes ... Global Forecasts & Trends to 2018", published by MarketsandMarkets, ... in geographies such as North America ... , and the Rest of the World (RoW). ...
Breaking Biology Technology:SoundConnect Organization and Culture is Evolving 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4A new way to make microstructured surfaces 2Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3
... 6 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... development and commercialization of novel drugs in the,therapeutic ... that it will host a conference call and ... Thursday, August 14, 2008 at 10:00,a.m. (EDT). Michael ...
... Nanochannel Chip and Reader for,Single-Molecule Mapping, Enabling Direct Visualization ... Strands of DNA in Context and at ... BioNanomatrix, Inc., a developer,of breakthrough nanoscale whole genome imaging ... announced,receipt of a grant from the National Human Genome ...
... YORK and HAIKOU CITY, China, Aug. 6 /Xinhua-PRNewswire-FirstCall/,-- ... Board: CPHI),which develops, manufactures, and markets generic and ... results,for the second quarter of 2008., ... revenues increased 31.6% to $11.28 million -- ...
Cached Biology Technology:Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 3BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 2BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 3China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 2China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 3China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 4China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 5China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 6China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 7China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 8China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 9China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results 10
(Date:7/28/2014)... Ariz. - Reactions among minerals and organic compounds in ... carbon cycle, they provide energy for the deep biosphere, ... However, very little is known about how minerals influence ... State University have demonstrated how a common mineral acts ... negating the need for toxic solvents or expensive reagents. ...
(Date:7/28/2014)... School of Medicine have pinpointed a mechanism in part of ... the blood, linking it to both type 1 and type ... issue of Proceedings of the National Academies of Sciences ... located in a part of the hypothalamus known as ... motion that control glucose levels in the blood," said lead ...
(Date:7/28/2014)... genome of Solanum pennellii , a wild relative ... international group of researchers including the labs headed by ... Davis Department of Plant Biology. The new genome information ... The work, published July 27 in the journal ... colleagues at Aachen University in Germany. The UC Davis ...
Breaking Biology News(10 mins):Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3Glucose 'control switch' in the brain key to both types of diabetes 2
... children, on their exposure to molds or dampness in their ... has greater or smaller beneficial effect against asthma, according to ... that vitamin C might be beneficial in the treatment of ... controlled trials have been conflicting., Drs Mohammed Al-Biltagi from the ...
... One of the world,s strangest animals a unique fish ... no legs has a rich and complex social life, a ... blenny ( Alticus arnoldorum ) has been detailed for the first ... life first evolved to colonise the land., The Pacific leaping blenny ...
... to swine flu, virus outbreaks can be unpredictable and ... networking site Facebook, developed in a Tel Aviv University lab, ... infections spread among populations. Dr. Gal Almogy and ... Biology at TAU,s George S. Wise Faculty of Life Sciences ...
Cached Biology News:Landlubber fish leap for love when tide is right 2Watching viruses 'friend' a network 2Watching viruses 'friend' a network 3
... Orbital Shaker is designed to be a solid, ... motion that is both mixing and vortexing in ... provides a smooth, quiet, reproducible and uniform orbital ... of laboratory applications such as cell/tissue culture, hybridization, ...
... The Biometra TProfessional Thermocycler combines top ... silver block achieves high speed and unparalleled ... graphical display providing programming in a spreadsheet ... High Performance Smart Lid opens on the ...
... Isolation Kit provides all the reagents ... vesicle fraction. The isolation procedure involves ... synaptosomes, and differential centrifugation followed by ... also contains an antibody specific for ...
... DNA Kit enables efficient extraction of DNA fragments from ... agarose gels. The procedure uses GelMelt solution to dissolve ... to a silica membrane in a spin column format. ... in low-salt buffer. Each spin column can bind up ...
Biology Products: